Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enexor Health Systems was a U.S. medical device company and wholly owned subsidiary of Enexor that was formed in 2020 to design and manufacture critical care ventilators during the COVID-19 pandemic. Its lead and apparently sole product was the Enexor VENT-LS, a piston-driven ventilator developed for hospital use and granted U.S. FDA Emergency Use Authorization in April 2020. The company emphasized durable, lower-cost ventilator design, rapid manufacturability, and deployment in underserved hospitals in the U.S. and internationally. Available evidence suggests the business was a short-lived pandemic-era healthcare initiative rather than a diversified biotech or therapeutics company, and it does not appear to remain an active standalone operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enexor Health Systems.